🔎 Trials Near Me

Home › Burkitt Lymphoma › Connecticut › New Haven

Burkitt Lymphoma clinical trials in New Haven, CT

6 studies for Burkitt Lymphoma are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

RecruitingPhase 3
  • Yale University, New Haven
Ages 18 to 39 · All sexes · Updated Oct 2, 2026 · NCT03150693

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

RecruitingPhase 1/2
  • Yale New Haven Hospital ( Site 1012), New Haven
6 Months – 25 Years · All sexes · Updated Sep 17, 2026 · NCT06395103

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RecruitingPhase 3
  • Yale University, New Haven
365 Days – 25 Years · All sexes · Updated Aug 25, 2026 · NCT03959085

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

RecruitingPhase 2
  • Yale University School of Medicine, New Haven
Ages 1 to 25 · All sexes · Updated May 4, 2025 · NCT03509961

Burkitt Lymphoma trials in other cities

Other studies in New Haven

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.